医学美学美容(中旬刊)
醫學美學美容(中旬刊)
의학미학미용(중순간)
MEDICAL AESTHETICS AND COSMETOLOGY
2014年
6期
38-39
,共2页
贺亮%黄凌杉%蒙荣钦%虞晓林
賀亮%黃凌杉%矇榮欽%虞曉林
하량%황릉삼%몽영흠%우효림
艾迪注射液%化疗治疗%晚期%非小细胞肺癌
艾迪註射液%化療治療%晚期%非小細胞肺癌
애적주사액%화료치료%만기%비소세포폐암
eddy injection%Chemotherapy treatment%The late%Non -smal celllung cancer
目的:观察艾迪注射液联合化疗治疗晚期 NSCLC 的临床效果,探讨提高治疗 NSCLC 临床疗效的方法。方法选择诊断为晚期 NSCLC 患者120例,随机均分为对照组和观察组,对照组采用多西紫杉醇+顺泊治疗,观察组在以上治疗的基础上,加用艾迪注射液治疗。比较两组患者治疗2个疗程后临床疗效、生活质量(Kamofsky 评分)和毒副反应情况。结果观察组与对照组在临床疗效方面比较,无显著性差异(P >0.05);在治疗后生活质量及毒副反应方面比较,具有(高度)统计学意义(P <0.05,P <0.01)。结论艾迪注射液联合化疗治疗晚期 NSCLC,可改善患者生活质量,减轻毒副反应,增强患者对化疗的耐受性,提高对化疗的依从性。
目的:觀察艾迪註射液聯閤化療治療晚期 NSCLC 的臨床效果,探討提高治療 NSCLC 臨床療效的方法。方法選擇診斷為晚期 NSCLC 患者120例,隨機均分為對照組和觀察組,對照組採用多西紫杉醇+順泊治療,觀察組在以上治療的基礎上,加用艾迪註射液治療。比較兩組患者治療2箇療程後臨床療效、生活質量(Kamofsky 評分)和毒副反應情況。結果觀察組與對照組在臨床療效方麵比較,無顯著性差異(P >0.05);在治療後生活質量及毒副反應方麵比較,具有(高度)統計學意義(P <0.05,P <0.01)。結論艾迪註射液聯閤化療治療晚期 NSCLC,可改善患者生活質量,減輕毒副反應,增彊患者對化療的耐受性,提高對化療的依從性。
목적:관찰애적주사액연합화료치료만기 NSCLC 적림상효과,탐토제고치료 NSCLC 림상료효적방법。방법선택진단위만기 NSCLC 환자120례,수궤균분위대조조화관찰조,대조조채용다서자삼순+순박치료,관찰조재이상치료적기출상,가용애적주사액치료。비교량조환자치료2개료정후림상료효、생활질량(Kamofsky 평분)화독부반응정황。결과관찰조여대조조재림상료효방면비교,무현저성차이(P >0.05);재치료후생활질량급독부반응방면비교,구유(고도)통계학의의(P <0.05,P <0.01)。결론애적주사액연합화료치료만기 NSCLC,가개선환자생활질량,감경독부반응,증강환자대화료적내수성,제고대화료적의종성。
objective to observe the eddy injection for treatment of advanced NSCLC with combination chemotherapy,clinical curative ef ect of the treatment of NSCLC are discussed. Methods select 120 cases diagnosed as late -stage NSCLC patients,randomly divided into control group and observation group,control group treated with docetaxel +suitable berth,observation group on the basis of the above treatment,and treatment with eddy injection.Compare two groups of patients after 2 courses of clinical ef icacy,quality of life (Kamofsky score)and adverse re-action.Results the observation group compared with control group in the aspect of clinical curative ef ect,no significant dif erence (P >0.05);After treatment the quality of life and adverse reaction of comparison,(level)statistical significance (P <0.05,P <0.01).Conclusion eddy injection combined with chemotherapy treatment of advanced NSCLC,can improve the patients quality of life,reduce adverse reactions,enhance patients tolerance to chemotherapy and improve the compliance of chemotherapy.